Becton, Dickinson and Company
BDX
•Stock Analysis$189.10
+0.00 (+0.00%)• Live
Becton, Dickinson and Company Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Becton, Dickinson and Company
Key Financial Metrics
for Becton, Dickinson and Company
P/E Ratio
33.25
Revenue Growth
+4.16%
EPS Growth
+18.31%
Market Cap
$49.50B
Dividend Yield
+2.36%
Debt/Equity
0.76
ROIC
+4.35%
FCF Yield
+5.23%
View additional metrics
Valuation
P/B Ratio1.97
EV/Sales3.26
Financial Health
Current Ratio1.13
Return on Assets+8.37%
Analyst Recommendations
for Becton, Dickinson and Company
32 analysts
Consensus: Hold
About
for Becton, Dickinson and Company
Company Details
for Becton, Dickinson and Company
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas E. Polen Jr.
Employees
70,000
Market Cap
54.20B
Exchange
New York Stock Exchange
IPO Date
February 21, 1973
Website
www.bd.comCIK
0000010795
ISIN
US0758871091
CUSIP
075887109
Country
US
Balance Sheet
for Becton, Dickinson and Company
Cash Flow Statement
for Becton, Dickinson and Company
Income Statement
for Becton, Dickinson and Company
News
No news available at the moment.